Tandem Diabetes Care(TNDM)
搜索文档
Tandem Diabetes Care(TNDM) - 2023 Q2 - Earnings Call Transcript
2023-08-04 10:16
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q2 2023 Results Conference Call August 3, 2023 4:30 PM ET Company Participants Susan Morrison - EVP, CAO John Sheridan - President, CEO Leigh Vosseller - EVP, CFO Conference Call Participants Alex Nowak - Craig-Hallum Chris Pasquale - Nephron Research Danielle Antalffy - UBS Jayson Bedford - Raymond James Joanne Wuensch - Citibank Matt Taylor - Jefferies Matt Miksic - Barclays Steve Lichtman - Oppenheimer Operator Thank you for standing by, and welcome to Tandem Sec ...
Tandem Diabetes Care(TNDM) - 2023 Q2 - Quarterly Report
2023-08-04 04:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________________________ FORM 10-Q _____________________________________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transi ...
Tandem Diabetes Care(TNDM) - 2023 Q1 - Quarterly Report
2023-05-04 04:12
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________________________ FORM 10-Q _____________________________________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Trans ...
Tandem Diabetes Care(TNDM) - 2022 Q4 - Annual Report
2023-02-23 05:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________________ FORM 10-K _________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36189 ______ ...